Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3515LS2W
Performance in the last:
Follow this Portfolio
1D 4.1 %
1W 4.0 %
2W 4.0 %
1M 3.7 %
3M -6.9 %
6M 3.3 %
9M -72.0 %
1Y -67.0 %
Alpha
-75.8%
Beta
0.29
sharpe-R
-0.85
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.5
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-11-22 08:47:53
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -75.48%
Max. DrawDown Benchmark -8.41%

This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 2 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 15.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

For Long-Short model portfolios, the short-selling costs (asset borrowing costs) are not taken into account. This assumption is likely unrealistic, and it is important to understand the short-selling process before employing this type of strategy.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
4

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Action Weight PnL
AVXL Anavex Life Sciences Corp. Buy 13.46% 9.47%
ALDX Aldeyra Therapeutics, Inc. Buy 11.97% -2.63%
MCRB Seres Therapeutics, Inc. Buy 13.07% 6.33%
RGEN Repligen Corporation Buy 12.55% 2.06%
NUTX Nutex Health Inc. Buy 12.93% 5.14%
CNC Centene Corporation Buy 12.56% 2.12%
CVS CVS Health Corporation Buy 12.36% 0.48%
VREX Varex Imaging Corporation Buy 13.17% 7.07%
TNDM Tandem Diabetes Care, Inc. Buy 12.54% 1.96%
CHRS Coherus BioSciences, Inc. Buy 12.3% 0%
BLUE bluebird bio, Inc. Sell -5.41% 6.25%
NKTR Nektar Therapeutics Sell -5.44% 5.61%
BHVN Biohaven Ltd. Sell -5.87% -1.8%
AXSM Axsome Therapeutics, Inc. Sell -6.08% -5.39%
IRWD Ironwood Pharmaceuticals, Inc. Sell -6.31% 5.11%
The percentage of cash held in the portfolio is: 2.18%
** The description of each asset is available Here

The latest 5 Compositions change

2024-11-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
AVXL Anavex Life Sciences Corp. Buy 12.91% 2.85%
ALDX Aldeyra Therapeutics, Inc. Buy 12.09% -3.64%
MCRB Seres Therapeutics, Inc. Buy 14.84% 18.25%
RGEN Repligen Corporation Buy 12.56% 0%
NUTX Nutex Health Inc. Buy 12.56% 0%
CNC Centene Corporation Buy 12.56% 0%
CVS CVS Health Corporation Buy 12.56% 0%
VREX Varex Imaging Corporation Buy 12.56% 0%
TNDM Tandem Diabetes Care, Inc. Buy 12.56% 0%
CHRS Coherus BioSciences, Inc. Buy 12.56% 0%
BLUE bluebird bio, Inc. Sell -5.52% 6.25%
NKTR Nektar Therapeutics Sell -5.5% 6.54%
BHVN Biohaven Ltd. Sell -6.21% -5.5%
AXSM Axsome Therapeutics, Inc. Sell -5.98% -1.53%
IRWD Ironwood Pharmaceuticals, Inc. Sell -6.79% 0%
The percentage of cash held in the portfolio is: 2.23%
New Assets Added
  • RGEN
  • NUTX
  • CNC
  • CVS
  • VREX
  • TNDM
  • CHRS
  • IRWD
Assets Removed
Asset Action Perf %
RGEN Buy All -11.36%
Assets Rebalanced
None
2024-11-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
AVXL Anavex Life Sciences Corp. Buy 12.8% 0%
ALDX Aldeyra Therapeutics, Inc. Buy 12.8% 0%
MCRB Seres Therapeutics, Inc. Buy 12.8% 0%
RGEN Repligen Corporation Sell -6.19% -3.01%
BLUE bluebird bio, Inc. Sell -5.73% 4.66%
NKTR Nektar Therapeutics Sell -5.78% 3.74%
BHVN Biohaven Ltd. Sell -6.26% -4.3%
AXSM Axsome Therapeutics, Inc. Sell -6.15% -2.46%
The percentage of cash held in the portfolio is: 91.71%
New Assets Added
  • AVXL
  • ALDX
  • MCRB
Assets Removed
None
Assets Rebalanced
None
2024-11-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGEN Repligen Corporation Sell -6% 0%
BLUE bluebird bio, Inc. Sell -6% 0%
NKTR Nektar Therapeutics Sell -6% 0%
BHVN Biohaven Ltd. Sell -6% 0%
AXSM Axsome Therapeutics, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 130%
New Assets Added
  • RGEN
  • BLUE
  • NKTR
  • BHVN
  • AXSM
Assets Removed
None
Assets Rebalanced
None
2024-10-24 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
TDOC Sell All -8.54%
BLFS Buy All 6.24%
SIGA Buy All -1.07%
Assets Rebalanced
None
2024-10-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
TDOC Teladoc Health, Inc. Buy 12.28% -5.06%
BLFS BioLife Solutions, Inc. Sell -5.83% 3.38%
SIGA SIGA Technologies, Inc. Sell -6.14% -1.68%
The percentage of cash held in the portfolio is: 99.69%
New Assets Added
None
Assets Removed
Asset Action Perf %
BLUE Buy All -3.2%
Assets Rebalanced
None
2024-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
TDOC Teladoc Health, Inc. Buy 12.92% 0.21%
BLUE bluebird bio, Inc. Sell -4.69% 0%
BLFS BioLife Solutions, Inc. Sell -5.95% 1.11%
SIGA SIGA Technologies, Inc. Sell -6.51% -8.1%
The percentage of cash held in the portfolio is: 104.22%
New Assets Added
None
Assets Removed
Asset Action Perf %
THC Buy All -3.17%
Assets Rebalanced
None
2024-10-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
TDOC Teladoc Health, Inc. Buy 13.21% 3.06%
THC Tenet Healthcare Corporation Sell -7.15% -4.65%
BLUE bluebird bio, Inc. Sell -4.58% 1.67%
BLFS BioLife Solutions, Inc. Sell -5.86% 1.92%
SIGA SIGA Technologies, Inc. Sell -6.22% -3.98%
The percentage of cash held in the portfolio is: 110.6%
New Assets Added
None
Assets Removed
Asset Action Perf %
BHVN Sell All -2.43%
RGNX Buy All -14.97%
Assets Rebalanced
None
2024-10-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
BHVN Biohaven Ltd. Buy 13.43% 0.04%
TDOC Teladoc Health, Inc. Buy 12.18% -5.16%
THC Tenet Healthcare Corporation Sell -6.78% 0.93%
RGNX REGENXBIO Inc. Sell -7.46% -9.09%
BLUE bluebird bio, Inc. Sell -4.76% -2.04%
BLFS BioLife Solutions, Inc. Sell -6% -0.17%
SIGA SIGA Technologies, Inc. Sell -6.18% -3.21%
The percentage of cash held in the portfolio is: 105.59%
New Assets Added
None
Assets Removed
Asset Action Perf %
VREX Sell All -4.95%
PCRX Sell All 8.44%
Assets Rebalanced
None
2024-10-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 12.27% -4.19%
PCRX Pacira BioSciences, Inc. Buy 13.81% 7.77%
BHVN Biohaven Ltd. Buy 13.57% 1.86%
TDOC Teladoc Health, Inc. Buy 12.36% -3.06%
THC Tenet Healthcare Corporation Sell -6.75% 0.59%
RGNX REGENXBIO Inc. Sell -7.18% -5.78%
BLUE bluebird bio, Inc. Sell -4.82% -4.08%
BLFS BioLife Solutions, Inc. Sell -5.74% 3.42%
SIGA SIGA Technologies, Inc. Sell -6.25% -5.05%
The percentage of cash held in the portfolio is: 78.74%
New Assets Added
None
Assets Removed
Asset Action Perf %
WBA Sell All 1.66%
Assets Rebalanced
None
2024-10-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
WBA Walgreens Boots Alliance, Inc. Buy 12.77% -0.33%
VREX Varex Imaging Corporation Buy 12.08% -5.79%
PCRX Pacira BioSciences, Inc. Buy 13.27% 3.52%
BHVN Biohaven Ltd. Buy 13% -2.46%
TDOC Teladoc Health, Inc. Buy 12.75% 0%
THC Tenet Healthcare Corporation Sell -6.62% 2.53%
RGNX REGENXBIO Inc. Sell -6.72% 1.18%
BLUE bluebird bio, Inc. Sell -4.64% 0%
BLFS BioLife Solutions, Inc. Sell -5.64% 5.13%
SIGA SIGA Technologies, Inc. Sell -6% -0.92%
The percentage of cash held in the portfolio is: 65.76%
New Assets Added
  • TDOC
Assets Removed
None
Assets Rebalanced
None
2024-10-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
WBA Walgreens Boots Alliance, Inc. Buy 12.63% -1.66%
VREX Varex Imaging Corporation Buy 12.39% -3.52%
PCRX Pacira BioSciences, Inc. Buy 13.3% 3.52%
BHVN Biohaven Ltd. Buy 12.98% -2.81%
THC Tenet Healthcare Corporation Sell -6.69% 1.7%
RGNX REGENXBIO Inc. Sell -6.73% 1.18%
BLUE bluebird bio, Inc. Sell -4.65% 0%
BLFS BioLife Solutions, Inc. Sell -5.96% 0%
SIGA SIGA Technologies, Inc. Sell -5.96% 0%
The percentage of cash held in the portfolio is: 78.69%
New Assets Added
  • BLFS
  • SIGA
Assets Removed
Asset Action Perf %
ALDX Buy All 3.33%
Assets Rebalanced
None
2024-10-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
WBA Walgreens Boots Alliance, Inc. Buy 12.83% 0.22%
VREX Varex Imaging Corporation Buy 12.12% -5.37%
PCRX Pacira BioSciences, Inc. Buy 13.32% 4.05%
BHVN Biohaven Ltd. Buy 13.31% 0%
ALDX Aldeyra Therapeutics, Inc. Sell -7.3% 2.78%
THC Tenet Healthcare Corporation Sell -6.53% 3.82%
RGNX REGENXBIO Inc. Sell -6.91% -1.82%
BLUE bluebird bio, Inc. Sell -4.63% 0%
The percentage of cash held in the portfolio is: 73.79%
New Assets Added
  • BLUE
Assets Removed
Asset Action Perf %
BLUE Sell All NA
LXRX Buy All NA
KURA Buy All NA
Assets Rebalanced
None
2024-10-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
WBA Walgreens Boots Alliance, Inc. Buy 12.47% -2.1%
VREX Varex Imaging Corporation Buy 12% -5.79%
PCRX Pacira BioSciences, Inc. Buy 13.54% 6.25%
BLUE bluebird bio, Inc. Buy 10.48% 0%
BHVN Biohaven Ltd. Buy 13.25% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -5.25% -7.01%
KURA Kura Oncology, Inc. Sell -4.43% 9.74%
ALDX Aldeyra Therapeutics, Inc. Sell -7.31% 2.22%
THC Tenet Healthcare Corporation Sell -6.59% 2.47%
RGNX REGENXBIO Inc. Sell -6.88% -1.82%
The percentage of cash held in the portfolio is: 68.7%
New Assets Added
  • BHVN
Assets Removed
None
Assets Rebalanced
None
2024-10-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
WBA Walgreens Boots Alliance, Inc. Buy 12.12% -3.75%
VREX Varex Imaging Corporation Buy 12.21% -3.1%
PCRX Pacira BioSciences, Inc. Buy 13.83% 9.77%
BLUE bluebird bio, Inc. Buy 11.36% 9.62%
LXRX Lexicon Pharmaceuticals, Inc. Sell -5.22% -7.64%
KURA Kura Oncology, Inc. Sell -4.41% 8.98%
ALDX Aldeyra Therapeutics, Inc. Sell -7.31% 1.11%
THC Tenet Healthcare Corporation Sell -6.67% 0.11%
RGNX REGENXBIO Inc. Sell -6.94% -3.96%
The percentage of cash held in the portfolio is: 81.04%
New Assets Added
None
Assets Removed
Asset Action Perf %
PDSB Sell All 10.09%
Assets Rebalanced
None
2024-10-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 14.83% 17.51%
WBA Walgreens Boots Alliance, Inc. Buy 12.08% -4.3%
VREX Varex Imaging Corporation Buy 12.06% -4.45%
PCRX Pacira BioSciences, Inc. Buy 13.33% 5.58%
BLUE bluebird bio, Inc. Buy 10.38% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -4.98% -2.55%
KURA Kura Oncology, Inc. Sell -4.46% 8.27%
ALDX Aldeyra Therapeutics, Inc. Sell -7.17% 3.15%
THC Tenet Healthcare Corporation Sell -6.69% 0%
RGNX REGENXBIO Inc. Sell -6.69% 0%
The percentage of cash held in the portfolio is: 67.31%
New Assets Added
  • BLUE
  • THC
  • RGNX
Assets Removed
None
Assets Rebalanced
None
2024-10-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 13.86% 8.31%
WBA Walgreens Boots Alliance, Inc. Buy 12.29% -3.97%
VREX Varex Imaging Corporation Buy 12.74% -0.5%
PCRX Pacira BioSciences, Inc. Buy 13.01% 1.66%
LXRX Lexicon Pharmaceuticals, Inc. Sell -4.96% -0.64%
KURA Kura Oncology, Inc. Sell -4.77% 3.08%
ALDX Aldeyra Therapeutics, Inc. Sell -7.35% 2.04%
The percentage of cash held in the portfolio is: 65.19%
New Assets Added
None
Assets Removed
Asset Action Perf %
OMI Sell All -10.07%
KIDS Buy All 16.7%
Assets Rebalanced
None
2024-10-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
OMI Owens & Minor, Inc. Buy 12.25% -3.03%
PDSB PDS Biotechnology Corporation Buy 14.32% 13.35%
WBA Walgreens Boots Alliance, Inc. Buy 12.49% -1.1%
VREX Varex Imaging Corporation Buy 12.64% 0%
PCRX Pacira BioSciences, Inc. Buy 12.64% 0%
KIDS OrthoPediatrics Corp. Sell -6.28% 12.77%
LXRX Lexicon Pharmaceuticals, Inc. Sell -4.86% 0%
KURA Kura Oncology, Inc. Sell -4.79% 1.41%
ALDX Aldeyra Therapeutics, Inc. Sell -7.4% 0.19%
The percentage of cash held in the portfolio is: 59%
New Assets Added
  • VREX
  • PCRX
Assets Removed
Asset Action Perf %
CHRS Buy All 0.95%
Assets Rebalanced
None
2024-09-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
OMI Owens & Minor, Inc. Buy 12.8% 0%
PDSB PDS Biotechnology Corporation Buy 12.8% 0%
WBA Walgreens Boots Alliance, Inc. Buy 12.8% 0%
CHRS Coherus BioSciences, Inc. Sell -6.32% 0%
KIDS OrthoPediatrics Corp. Sell -6.21% 14.86%
LXRX Lexicon Pharmaceuticals, Inc. Sell -5.02% -1.91%
KURA Kura Oncology, Inc. Sell -4.85% 1.51%
ALDX Aldeyra Therapeutics, Inc. Sell -7.65% -1.85%
The percentage of cash held in the portfolio is: 91.66%
New Assets Added
  • OMI
  • PDSB
  • WBA
Assets Removed
Asset Action Perf %
TDOC Sell All 4.57%
Assets Rebalanced
None
2024-09-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
TDOC Teladoc Health, Inc. Buy 12.59% 3.96%
CHRS Coherus BioSciences, Inc. Sell -6.36% -0.95%
KIDS OrthoPediatrics Corp. Sell -6.12% 15.83%
LXRX Lexicon Pharmaceuticals, Inc. Sell -4.82% 1.91%
KURA Kura Oncology, Inc. Sell -4.82% 1.82%
ALDX Aldeyra Therapeutics, Inc. Sell -7.44% 0.56%
The percentage of cash held in the portfolio is: 116.98%
New Assets Added
None
Assets Removed
Asset Action Perf %
VNDA Sell All -4.44%
SRNE Sell All -16.67%
LLY Sell All -2.75%
Assets Rebalanced
None
2024-09-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
SRNE Sorrento Therapeutics, Inc. Buy 10.15% -40%
LLY Eli Lilly and Company Buy 12.7% -1.12%
TDOC Teladoc Health, Inc. Buy 13.05% 4.7%
VNDA Vanda Pharmaceuticals Inc. Buy 12.92% -2.22%
CHRS Coherus BioSciences, Inc. Sell -6.12% 5.62%
KIDS OrthoPediatrics Corp. Sell -6.32% 15.6%
LXRX Lexicon Pharmaceuticals, Inc. Sell -4.86% 3.82%
KURA Kura Oncology, Inc. Sell -4.99% 1.26%
ALDX Aldeyra Therapeutics, Inc. Sell -7.7% 0%
The percentage of cash held in the portfolio is: 81.18%
New Assets Added
  • ALDX
Assets Removed
Asset Action Perf %
ESPR Sell All -7.47%
AGEN Sell All -15.18%
MRSN Sell All -14.69%
SIGA Buy All 10.12%
Assets Rebalanced
None
2024-09-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ESPR Esperion Therapeutics, Inc. Buy 13.99% -5.17%
SRNE Sorrento Therapeutics, Inc. Buy 9.6% -43.33%
AGEN Agenus Inc. Buy 13.05% -12.82%
LLY Eli Lilly and Company Buy 12.72% -1.13%
MRSN Mersana Therapeutics, Inc. Buy 12.09% -10.66%
TDOC Teladoc Health, Inc. Buy 13.61% 9.02%
VNDA Vanda Pharmaceuticals Inc. Buy 13.23% 0%
SIGA SIGA Technologies, Inc. Sell -7.12% -6.66%
CHRS Coherus BioSciences, Inc. Sell -6.19% 4.76%
KIDS OrthoPediatrics Corp. Sell -6.56% 12.52%
LXRX Lexicon Pharmaceuticals, Inc. Sell -5.06% 0%
KURA Kura Oncology, Inc. Sell -5.06% 0%
The percentage of cash held in the portfolio is: 41.7%
New Assets Added
  • VNDA
  • LXRX
  • KURA
Assets Removed
Asset Action Perf %
PDSB Sell All 3.99%
NVAX Sell All 4.65%
RGNX Sell All -11.8%
VKTX Sell All -12.12%
CARA Buy All 0.36%
BGNE Buy All -6.64%
Assets Rebalanced
None
2024-09-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 13.52% 4.32%
NVAX Novavax, Inc. Buy 12.8% 0.79%
ESPR Esperion Therapeutics, Inc. Buy 13.22% -6.32%
RGNX REGENXBIO Inc. Buy 13.25% -8.18%
SRNE Sorrento Therapeutics, Inc. Buy 13.51% -16.67%
AGEN Agenus Inc. Buy 12.8% -10.62%
LLY Eli Lilly and Company Buy 12.08% -1.76%
MRSN Mersana Therapeutics, Inc. Buy 11.94% -7.82%
TDOC Teladoc Health, Inc. Buy 12.8% 7.17%
VKTX Viking Therapeutics, Inc. Buy 12.09% -7.75%
CARA Cara Therapeutics, Inc. Sell -6.95% -7.12%
SIGA SIGA Technologies, Inc. Sell -7.17% -12.25%
BGNE BeiGene, Ltd. Sell -6.57% -2.57%
CHRS Coherus BioSciences, Inc. Sell -6.15% 0.95%
KIDS OrthoPediatrics Corp. Sell -6.3% 12.23%
The percentage of cash held in the portfolio is: 5.14%
New Assets Added
None
Assets Removed
None
Assets Rebalanced
Asset Action Weight
MRSN Sell -1.53%
LLY Sell -3.18%
TDOC Sell -2.86%
SRNE Buy 0.79%
AGEN Buy 1.65%
NVAX Buy 2.12%
2024-09-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 12.62% 6.31%
NVAX Novavax, Inc. Buy 9.87% 1.65%
ESPR Esperion Therapeutics, Inc. Buy 12.48% -3.45%
RGNX REGENXBIO Inc. Buy 12.16% -8.03%
SRNE Sorrento Therapeutics, Inc. Buy 15.4% 16.67%
AGEN Agenus Inc. Buy 11.26% -1.52%
LLY Eli Lilly and Company Buy 14.03% -1.45%
TDOC Teladoc Health, Inc. Buy 14.48% 8.16%
MRSN Mersana Therapeutics, Inc. Buy 13.7% 2.37%
VKTX Viking Therapeutics, Inc. Buy 12.01% 0%
CARA Cara Therapeutics, Inc. Sell -6.39% -7.47%
SIGA SIGA Technologies, Inc. Sell -6.57% -12.25%
BGNE BeiGene, Ltd. Sell -6.04% -2.91%
CHRS Coherus BioSciences, Inc. Sell -5.53% 2.86%
KIDS OrthoPediatrics Corp. Sell -6.08% 7.53%
The percentage of cash held in the portfolio is: 2.61%
New Assets Added
  • VKTX
Assets Removed
Asset Action Perf %
IRTC Sell All -8.63%
Assets Rebalanced
None
2024-09-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 12.18% 1.99%
NVAX Novavax, Inc. Buy 9.66% -1.1%
ESPR Esperion Therapeutics, Inc. Buy 13.01% 0%
RGNX REGENXBIO Inc. Buy 13.11% -1.42%
SRNE Sorrento Therapeutics, Inc. Buy 13.29% 0%
AGEN Agenus Inc. Buy 11.73% 2.02%
LLY Eli Lilly and Company Buy 13.87% -3.21%
TDOC Teladoc Health, Inc. Buy 15.13% 12.36%
MRSN Mersana Therapeutics, Inc. Buy 13.53% 0.47%
IRTC iRhythm Technologies, Inc. Buy 12.49% -7.28%
CARA Cara Therapeutics, Inc. Sell -6.09% -1.78%
SIGA SIGA Technologies, Inc. Sell -6.25% -6.13%
BGNE BeiGene, Ltd. Sell -5.94% -0.51%
CHRS Coherus BioSciences, Inc. Sell -5.73% 0%
KIDS OrthoPediatrics Corp. Sell -6.4% 3.28%
The percentage of cash held in the portfolio is: 2.4%
New Assets Added
None
Assets Removed
None
Assets Rebalanced
Asset Action Weight
RGNX Buy 1.02%
LLY Buy 1.67%
PDSB Buy 2.22%
2024-09-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.1% 3.65%
NVAX Novavax, Inc. Buy 9.92% 1.81%
ESPR Esperion Therapeutics, Inc. Buy 13.26% 2.3%
RGNX REGENXBIO Inc. Buy 12.14% 1.89%
AGEN Agenus Inc. Buy 12.05% 5.06%
LLY Eli Lilly and Company Buy 11.11% -3.08%
SRNE Sorrento Therapeutics, Inc. Buy 12.14% -8.33%
IRTC iRhythm Technologies, Inc. Buy 12.53% -6.66%
TDOC Teladoc Health, Inc. Buy 15.12% 12.61%
MRSN Mersana Therapeutics, Inc. Buy 12.98% -3.32%
CARA Cara Therapeutics, Inc. Sell -5.67% 4.98%
SIGA SIGA Technologies, Inc. Sell -6.16% -4.93%
BGNE BeiGene, Ltd. Sell -5.93% -0.63%
CHRS Coherus BioSciences, Inc. Sell -5.66% 0.95%
KIDS OrthoPediatrics Corp. Sell -6.59% 0%
The percentage of cash held in the portfolio is: 8.65%
New Assets Added
  • KIDS
Assets Removed
None
Assets Rebalanced
Asset Action Weight
ESPR Buy 1.41%
RGNX Buy 1.46%
SRNE Buy 1.63%
2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.16% 1.66%
NVAX Novavax, Inc. Buy 10.38% 3.94%
RGNX REGENXBIO Inc. Buy 10.78% 0.24%
ESPR Esperion Therapeutics, Inc. Buy 10.88% 1.15%
SRNE Sorrento Therapeutics, Inc. Buy 10.39% -11.67%
AGEN Agenus Inc. Buy 12.06% 2.53%
LLY Eli Lilly and Company Buy 11.62% -1.23%
IRTC iRhythm Technologies, Inc. Buy 13.25% -3.8%
TDOC Teladoc Health, Inc. Buy 13.89% 0.87%
MRSN Mersana Therapeutics, Inc. Buy 12.86% -6.64%
CARA Cara Therapeutics, Inc. Sell -5.83% 4.63%
SIGA SIGA Technologies, Inc. Sell -6.41% -6.39%
BGNE BeiGene, Ltd. Sell -6.04% -0.09%
CHRS Coherus BioSciences, Inc. Sell -5.86% 0%
The percentage of cash held in the portfolio is: 7.88%
New Assets Added
  • CHRS
Assets Removed
None
Assets Rebalanced
None
2024-09-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 9.82% -0.33%
NVAX Novavax, Inc. Buy 10.56% 7.17%
RGNX REGENXBIO Inc. Buy 10.72% 1.02%
ESPR Esperion Therapeutics, Inc. Buy 11.65% 9.77%
SRNE Sorrento Therapeutics, Inc. Buy 8.7% -25%
AGEN Agenus Inc. Buy 12.25% 5.56%
LLY Eli Lilly and Company Buy 11.46% -1.21%
IRTC iRhythm Technologies, Inc. Buy 13.59% 0%
TDOC Teladoc Health, Inc. Buy 13.59% 0%
MRSN Mersana Therapeutics, Inc. Buy 13.59% 0%
CARA Cara Therapeutics, Inc. Sell -5.65% 6.41%
SIGA SIGA Technologies, Inc. Sell -6.25% -5.19%
BGNE BeiGene, Ltd. Sell -6.03% -1.13%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • IRTC
  • TDOC
  • MRSN
Assets Removed
None
Assets Rebalanced
None
2024-09-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.02% 1.33%
NVAX Novavax, Inc. Buy 9.28% -6.14%
RGNX REGENXBIO Inc. Buy 10.2% -4.17%
ESPR Esperion Therapeutics, Inc. Buy 10.71% 0.57%
SRNE Sorrento Therapeutics, Inc. Buy 11.64% 0%
AGEN Agenus Inc. Buy 11.64% 0%
LLY Eli Lilly and Company Buy 11.64% 0%
CARA Cara Therapeutics, Inc. Sell -5.82% 3.91%
SIGA SIGA Technologies, Inc. Sell -6.25% -4.79%
BGNE BeiGene, Ltd. Sell -5.98% 0%
The percentage of cash held in the portfolio is: 42.9%
New Assets Added
  • SRNE
  • AGEN
  • LLY
  • BGNE
Assets Removed
None
Assets Rebalanced
None
2024-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.12% 2.99%
NVAX Novavax, Inc. Buy 9.51% -3.23%
RGNX REGENXBIO Inc. Buy 10.58% 0%
ESPR Esperion Therapeutics, Inc. Buy 10.58% 0%
CARA Cara Therapeutics, Inc. Sell -6.3% -4.63%
SIGA SIGA Technologies, Inc. Sell -5.93% 0%
The percentage of cash held in the portfolio is: 71.42%
New Assets Added
  • RGNX
  • ESPR
  • SIGA
Assets Removed
None
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 9.8% 0%
NVAX Novavax, Inc. Buy 9.8% 0%
CARA Cara Therapeutics, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 86.4%
New Assets Added
  • PDSB
  • NVAX
  • CARA
Assets Removed
None
Assets Rebalanced
None
2024-08-30 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
KIDS Sell All 12.95%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings